ArticleCancer management and research2013

Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases.

John Longo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.